These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36549559)

  • 21. An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration.
    Chen X; Burton C; Song X; McNamara L; Langella A; Cianetti S; Chang CH; Wang J
    Int J Biol Sci; 2009 Jul; 5(5):489-99. PubMed ID: 19680471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
    Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
    Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma.
    Kuai R; Subramanian C; White PT; Timmermann BN; Moon JJ; Cohen MS; Schwendeman A
    Int J Nanomedicine; 2017; 12():6581-6594. PubMed ID: 28919755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein A-I (ApoA-I) mimetic peptide P2a by restoring cholesterol esterification unmasks ApoA-I anti-inflammatory endogenous activity in vivo.
    Bucci M; Cigliano L; Vellecco V; D'Andrea LD; Ziaco B; Rossi A; Sautebin L; Carlucci A; Abrescia P; Pedone C; Ianaro A; Cirino G
    J Pharmacol Exp Ther; 2012 Mar; 340(3):716-22. PubMed ID: 22171091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin: cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells.
    Ohnsorg PM; Mary JL; Rohrer L; Pech M; Fingerle J; von Eckardstein A
    Biochim Biophys Acta; 2011 Dec; 1811(12):1115-23. PubMed ID: 21930241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage.
    White CR; Datta G; Wilson L; Palgunachari MN; Anantharamaiah GM
    Chem Phys Lipids; 2019 Mar; 219():28-35. PubMed ID: 30707910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
    Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
    Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An apolipoprotein A-I mimetic dose-dependently increases the formation of prebeta1 HDL in human plasma.
    Troutt JS; Alborn WE; Mosior MK; Dai J; Murphy AT; Beyer TP; Zhang Y; Cao G; Konrad RJ
    J Lipid Res; 2008 Mar; 49(3):581-7. PubMed ID: 18056684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Compendium of the Biological Effects of Apolipoprotein A-I
    Parolini C
    J Pharmacol Exp Ther; 2020 Jan; 372(1):54-62. PubMed ID: 31649050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein.
    Gu X; Wu Z; Huang Y; Wagner MA; Baleanu-Gogonea C; Mehl RA; Buffa JA; DiDonato AJ; Hazen LB; Fox PL; Gogonea V; Parks JS; DiDonato JA; Hazen SL
    J Biol Chem; 2016 Mar; 291(12):6386-95. PubMed ID: 26797122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The A's Have It: Developing Apolipoprotein A-I Mimetic Peptides Into a Novel Treatment for Asthma.
    Yao X; Gordon EM; Barochia AV; Remaley AT; Levine SJ
    Chest; 2016 Aug; 150(2):283-8. PubMed ID: 27327118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
    Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ
    Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MD simulations suggest important surface differences between reconstituted and circulating spherical HDL.
    Segrest JP; Jones MK; Catte A
    J Lipid Res; 2013 Oct; 54(10):2718-32. PubMed ID: 23856070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.
    Anantharamaiah GM; Garber DW; White CR
    Protein Pept Lett; 2016; 23(11):1024-1031. PubMed ID: 27586181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological properties of apolipoprotein a-I mimetic peptides.
    Getz GS; Wool GD; Reardon CA
    Curr Atheroscler Rep; 2010 Mar; 12(2):96-104. PubMed ID: 20425244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein A-I structural modification and the functionality of reconstituted high density lipoprotein particles in cellular cholesterol efflux.
    Gillotte KL; Davidson WS; Lund-Katz S; Rothblat GH; Phillips MC
    J Biol Chem; 1996 Sep; 271(39):23792-8. PubMed ID: 8798607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux.
    Islam RM; Pourmousa M; Sviridov D; Gordon SM; Neufeld EB; Freeman LA; Perrin BS; Pastor RW; Remaley AT
    Sci Rep; 2018 Feb; 8(1):2956. PubMed ID: 29440748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein A-I mimetic peptides.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Yu N; Ansell BJ; Datta G; Garber DW; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1325-31. PubMed ID: 15831812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
    Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
    Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel apoA-I mimetic peptide suppresses atherosclerosis by promoting physiological HDL function in apoE
    Gou S; Wang L; Zhong C; Chen X; Ouyang X; Li B; Bao G; Liu H; Zhang Y; Ni J
    Br J Pharmacol; 2020 Oct; 177(20):4627-4644. PubMed ID: 32726461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.